Nonadherence to Oral Medications for Chronic Conditions in Breast Cancer Survivors [CARE DELIVERY]
Conclusion:
Decreased adherence to medications for chronic diseases was found in the first year after breast cancer treatment. Breast cancer survivors may need additional interventions to improve their adherence to their medications for chronic conditions. (Source: Journal of Oncology Practice)
Source: Journal of Oncology Practice - August 9, 2016 Category: Cancer & Oncology Authors: Yang, J., Neugut, A. I., Wright, J. D., Accordino, M., Hershman, D. L. Tags: Doctor-patient communication, Pharmacoeconomics, Pharmacogenetics (including pharmacogenomics), Survivorship, Caregiver, Cost of care, Patient, Survivor, Access to care, Epidemiology, Behavioral and Lifestyle Risk Factors, Population and Observational Stu Source Type: research
Electronic Release of Pathology and Radiology Results to Patients: Opinions and Experiences of Oncologists [CARE DELIVERY]
Conclusion:
Almost half of oncologists reported that sharing digital radiology and pathology records had a negative impact on their communication with patients. Patient surveys in similar cancer populations would complement the physician perspective. Efforts are needed to improve consensus among oncologists and patients on how to best communicate such results in a timely fashion. (Source: Journal of Oncology Practice)
Source: Journal of Oncology Practice - August 9, 2016 Category: Cancer & Oncology Authors: Winget, M., Haji-Sheikhi, F., Brown-Johnson, C., Rosenthal, E. L., Sharp, C., Buyyounouski, M. K., Asch, S. M. Tags: Communication, Doctor-patient communication, Patient safety, Quality of care, Caregiver, Family member, Patient CARE DELIVERY Source Type: research
Acute, Unilateral Breast Toxicity From Gemcitabine in the Setting of Thoracic Inlet Obstruction [Case Report]
(Source: Journal of Oncology Practice)
Source: Journal of Oncology Practice - August 9, 2016 Category: Cancer & Oncology Authors: Weiskopf, K., Creighton, D., Lew, T., Caswell, J. L., Ouyang, D., Shah, A. T., Hofmann, L. V., Neal, J. W., Telli, M. L. Tags: Management and treatment, Patient safety, Adult Medical Oncology, Chemotherapy, Imaging, General/Other Radiology Case Report Source Type: research
Management of Chronic Pain in Survivors of Adult Cancers: ASCO Clinical Practice Guideline Summary [Guideline Summaries]
(Source: Journal of Oncology Practice)
Source: Journal of Oncology Practice - August 9, 2016 Category: Cancer & Oncology Authors: Paice, J. A., Lacchetti, C., Bruera, E. Tags: Clinical guidelines, Treatment related issues, Quality of care, Pain Control, ASCO Guidelines, Quality of Life, Quality of Care, Pain Control Guideline Summaries Source Type: research
Management of Depression in Patients With Cancer: A Clinical Practice Guideline [Guideline Summaries]
Conclusion:
This updated guideline supports the previous general recommendation that patients with cancer who have depression may benefit from psychological and/or pharmacologic interventions, without evidence for the superiority of any specific treatment over another. New recommendations for a collaborative care model that incorporates a stepped care approach suggest that multidisciplinary mental health care restructuring may be required for optimal management of depression. (Source: Journal of Oncology Practice)
Source: Journal of Oncology Practice - August 9, 2016 Category: Cancer & Oncology Authors: Li, M., Kennedy, E. B., Byrne, N., Gerin-Lajoie, C., Katz, M. R., Keshavarz, H., Sellick, S., Green, E. Tags: Non-ASCO Guidelines Guideline Summaries Source Type: research
Screening for Pancreatic Adenocarcinoma Using Signals From Web Search Logs: Feasibility Study and Results [FOCUS ON QUALITY]
Conclusion:
Signals in search logs show the possibilities of predicting a forthcoming diagnosis of pancreatic adenocarcinoma from combinations of subtle temporal signals revealed in the queries of searchers. (Source: Journal of Oncology Practice)
Source: Journal of Oncology Practice - August 9, 2016 Category: Cancer & Oncology Authors: Paparrizos, J., White, R. W., Horvitz, E. Tags: Information systems, Epidemiology, Diagnosis & Staging FOCUS ON QUALITY Source Type: research
Functional Organ Preservation in Larynx Cancer: A Continuing Debate [COMMENTARIES]
(Source: Journal of Oncology Practice)
Source: Journal of Oncology Practice - August 9, 2016 Category: Cancer & Oncology Authors: Dietz, A. Tags: Surgery, Combined Modality COMMENTARIES Source Type: research
A Multidisciplinary Approach to Larynx Cancer: One Size Does Not Fit All [COMMENTARIES]
(Source: Journal of Oncology Practice)
Source: Journal of Oncology Practice - August 9, 2016 Category: Cancer & Oncology Authors: Mowery, Y. M., Salama, J. K. Tags: Combined Modality COMMENTARIES Source Type: research
Multidisciplinary Care of Laryngeal Cancer [Clinical Reviews]
This article focuses on the multidisciplinary care of early-stage and locally advanced larynx cancer and attempts to sum up different approaches. Moreover, it reviews state-of-the-art treatment in larynx preservation, which has been consolidated in recent years. (Source: Journal of Oncology Practice)
Source: Journal of Oncology Practice - August 9, 2016 Category: Cancer & Oncology Authors: Salvador-Coloma, C., Cohen, E. Tags: Management and treatment, Combined Modality Clinical Reviews Source Type: research
Stereotactic Radiosurgery for Brain Metastases: More Work to Be Done [COMMENTARIES]
(Source: Journal of Oncology Practice)
Source: Journal of Oncology Practice - August 9, 2016 Category: Cancer & Oncology Authors: Monaco, E. A. Tags: Brain Tumors, Radiation, Radiation Oncology COMMENTARIES Source Type: research
Searching for Synergy: Combining Drugs and Stereotactic Radiosurgery for the Treatment of Brain Metastases [COMMENTARIES]
(Source: Journal of Oncology Practice)
Source: Journal of Oncology Practice - August 9, 2016 Category: Cancer & Oncology Authors: Shonka, N. A., Zhang, C. Tags: Clinical guidelines, Management and treatment COMMENTARIES Source Type: research
Stereotactic Radiosurgery for Treatment of Brain Metastases [Clinical Reviews]
Brain metastases are the most common intracranial malignancy. Incidence of brain metastases has risen as systemic therapies have improved and patients with metastatic disease live longer. Whole-brain radiation therapy, for many years, has been the standard treatment approach. Stereotactic radiosurgery has become an increasingly popular option because of its relatively short, convenient, and noninvasive treatment course. Although recently published data have renewed interest in use of whole-brain radiation therapy or systemic therapies for control of micrometastatic disease, stereotactic radiosurgery continues to be an impo...
Source: Journal of Oncology Practice - August 9, 2016 Category: Cancer & Oncology Authors: Badiyan, S. N., Regine, W. F., Mehta, M. Tags: Brain Tumors, Radiation Clinical Reviews Source Type: research
Better Screening Using Big Data [Editorial]
(Source: Journal of Oncology Practice)
Source: Journal of Oncology Practice - August 9, 2016 Category: Cancer & Oncology Authors: Patt, D. Tags: Editorial Source Type: research
Innovative Strategies for Decreasing Blood Collection Wait Times for Patients in Early-Phase Cancer Clinical Trials [Quality in Action]
Conclusion:
We observed a significant decrease in mean wait times after implementing our intervention. This decrease led to increased staff productivity and cost savings. Once wait times became a measurable metric, we were able to identify causes for delays and improve our operations, which can be performed in any patient care facility. (Source: Journal of Oncology Practice)
Source: Journal of Oncology Practice - July 11, 2016 Category: Cancer & Oncology Authors: Mengistu, B., Ray, D., Lockett, P., Dorsey, V., Phipps, R. A., Subramanian, H., Atkins, J. T., El Osta, B., Falchook, G. S., Karp, D. D. Tags: Information systems, Quality in Action, Information systems Source Type: research
Is FDA-Approved Bevacizumab Cost-Effective When Included in the Treatment of Platinum-Resistant Recurrent Ovarian Cancer? [FOCUS ON QUALITY]
Conclusion:
Using a willingness-to-pay threshold of $100,000 ICER, the addition of BEV to chemotherapy either demonstrates or approaches cost-effectiveness and NHB when added to the treatment of patients with PROC. (Source: Journal of Oncology Practice)
Source: Journal of Oncology Practice - July 11, 2016 Category: Cancer & Oncology Authors: Chappell, N. P., Miller, C. R., Fielden, A. D., Barnett, J. C. Tags: Cost of care, Chemotherapy FOCUS ON QUALITY Source Type: research
